Informed consent is a healthcare approach that recognises individuals as the primary authority on their own gender identity. Evidence shows this model can improve access to gender-affirming care whilst maintaining appropriate clinical standards. Rather than requiring extensive psychological evaluation or gatekeeping processes, informed consent allows people to access treatment after receiving comprehensive information about benefits, risks, and alternatives.
Research indicates that informed consent models can reduce barriers to care whilst maintaining safety outcomes. The approach combines patient autonomy with proper clinical oversight, ensuring people receive thorough information about hormonal treatments, potential side effects, and monitoring requirements. Guidelines from leading organisations increasingly support this model, recognising that lengthy assessment processes can delay necessary care without improving outcomes.
The informed consent framework still involves careful medical evaluation, including health assessments, laboratory monitoring, and ongoing clinical support. Healthcare providers remain responsible for ensuring patients understand treatment implications and receive appropriate follow-up care. This approach differs from traditional gatekeeping by placing trust in individuals' understanding of their own gender identity whilst maintaining clinical responsibility for safe prescribing practices.
People often ask whether informed consent compromises safety standards. Evidence suggests that when properly implemented with adequate counselling and monitoring, this model can provide effective care whilst respecting patient autonomy. The approach acknowledges that individuals seeking gender-affirming treatment have typically already engaged in significant self-reflection about their identity and needs.